Akèy › Kansè (tout kalite) › Iowa
Etid klinik pou Kansè (tout kalite) nan Iowa
17 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan Iowa.
Vil nan Iowa
Tèks ofisyèl etid la (Anglè)
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- University of Iowa Health, Iowa City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07192471uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- The State University of Iowa, Iowa City
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05874921A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- University of Iowa Hospitals ( Site 4017), Iowa City
Ap rekriteFaz 1/2
1 Month – 17 Years · Tout sèks · Mizajou Sep 25, 2026 · NCT07630974A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Holden Comprehensive Cancer Center, Iowa City
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06901531Prospective Study to Assess a Diagnostic Aid for Cancer
- Iowa Clinic, West Des Moines
Ap rekriteEtid obsèvasyon
Laj 45 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT07046260A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- University of Iowa Health Care Holden Comprehensive Cancer Center ( Site 3017), Iowa City
Ap rekriteFaz 1/2
1 Month – 17 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06941272Collection of Tissue Samples for Cancer Research
- University of Iowa, Iowa City
Ap rekriteEtid obsèvasyon
2 Months · Tout sèks · Mizajou Sep 16, 2026 · NCT00900198Lurbinectedin in FET-Fused Tumors
- University of Iowa Hospitals and Clinics, Iowa City
Ap rekriteFaz 1/2
Laj 10 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05918640Project: Every Child for Younger Patients With Cancer
- Blank Children's Hospital, Des Moines
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City
Ap rekriteEtid obsèvasyon
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Mary Greeley Medical Center, Ames
- McFarland Clinic - Ames, Ames
- Mercy Hospital, Cedar Rapids
- ak 7 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT06580314A Study of ASP1002 in Adults for Treatment of Solid Tumors
- University of Iowa Hospitals, Iowa City
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT05719558First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- University of Iowa, Iowa City
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139Molecular Genetics Studies of Cancer Patients and Their Relatives
- Mercy Hospital, Cedar Rapids
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Jun 29, 2026 · NCT04185935A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
- Mission Cancer + Blood - Mission Cancer Foundation, Des Moines
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 24, 2026 · NCT06010329GEMINI-NSCLC: NSCLC Biomarker Study
- University of Iowa, Iowa City
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT05236114Beat Childhood Cancer Specimen Banking and Data Registry
- University of Iowa, Iowa City
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou Feb 3, 2026 · NCT04715178SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Iowa City
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.